For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

This groundbreaking finding, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

Research shows that your education level can be another big factor. Researchers at University College London found that ...